The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection
Year: 2018
Type: review
Abstract: The coronary circulation is both culprit and victim of acute myocardial infarction. The rupture of an epicardial atherosclerotic plaque with superimposed thrombosis causes coronary occlusion, and this occlusion must be removed to induce reperfusion. However, ischaemia and reperfusion cause damage not only in cardiomyocytes but also in the coronary circulation, including microembolization of debris and release of soluble factors from the culprit lesion, impairment of endothelial integrity with subsequently increased permeability and oedema formation, platelet activation and leucocyte adherence, erythrocyte stasis, a shift from vasodilation to vasoconstriction, and ultimately structural damage to the capillaries with eventual no-reflow, microvascular obstruction (MVO), and intramyocardial haemorrhage (IMH). Therefore, the coronary circulation is a valid target for cardioprotection, beyond protection of the cardiomyocyte. Virtually all of the above deleterious endpoints have been demonstrated to be favourably influenced by one or the other mechanical or pharmacological cardioprotective intervention. However, no-reflow is still a serious complication of reperfused myocardial infarction and carries, independently from infarct size, an unfavourable prognosis. MVO and IMH can be diagnosed by modern imaging technologies, but still await an effective therapy. The current review provides an overview of strategies to protect the coronary circulation from acute myocardial ischaemia/reperfusion injury. This article is part of a Cardiovascular Research Spotlight Issue entitled 'Cardioprotection Beyond the Cardiomyocyte', and emerged as part of the discussions of the European Union (EU)-CARDIOPROTECTION Cooperation in Science and Technology (COST) Action, CA16225.
Source: Cardiovascular Research
DOI: 10.1093/cvr/cvy286
Institutions: St Bartholomew's Hospital, National University of Singapore, Duke-NUS Medical School, UCL Biomedical Research Centre, National Heart Centre Singapore, University College London, Northeast Ohio Medical University, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Semmelweis University, Pharmahungary Group (Hungary), Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Centro de Investigación en Red en Enfermedades Cardiovasculares, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Radboud University Medical Center, Justus-Liebig-Universität Gießen, West German Heart and Vascular Center Essen
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: National Institute for Health and Care Research, British Heart Foundation, University College London, European Cooperation in Science and Technology, Deutsche Forschungsgemeinschaft, Semmelweis Egyetem, Hungarian Scientific Research Fund, Ministry of Education, India, Emberi Eroforrások Minisztériuma, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, EU-CARDIOPROTECTION, Medical Research Council, National Medical Research Council, Instituto de Salud Carlos III, European Regional Development Fund, National Research, Development and Innovation Office
Awards: G1513026599, G1738013897, G1855335561, Effect of Remote Ischaemic preConditioning on Clinical outcomes in patients undergoing Coronary Artery bypass graft, G193747123, G2204319727, G2246005815, G2294835626, G245083819, G2490703178, G3207672262, G4173566781, G4212899957, G4469407262, G4503534332, G471312740, G499705307, G5532691452, G5613220980, G6612097543, Novel means of cardioprotection by exploiting pathways activated by Stromal Derived Factor-1α, G7268277117, Protecting the heart with a novel activator of the RISK pathway, G80800696, G966830504
OpenAlex ID: W2900781141
